The authors evaluated, in a community-based open-label trial, the effectiveness and safety of perindopril in 13,220 US hypertensive patients and studied how physicians adhere to hypertension ...

To evaluate the persistence of the antihypertensive effect of perindopril 4 mg+indapamide 1.25 mg once daily for up to 72 h using the ‘missed-dose’ technique. Hypertensive patients were ...

The Perindopril in Elderly People with Chronic Heart Failure study failed to show that perindopril could reduce long-term mortality or morbidity among elderly people with diastolic with heart failure.

Antihypertensive therapy lowered the risk of developing dementia after a recurrent stroke in the Perindopril Protection Against Recurrent Stroke Study (PROGRESS) trial. However, no significant ...

The dosage of perindopril and indapamide was increased to 4 mg and 1.25 mg, respectively, after 3 months' treatment. Study visits were every 6 months.